Polymorphisms in OX40/OX40L associated with enhanced protein expression have been described to be associated with SLE [56, 57] and human monosomy 1q36 evidences activated CD4+ T-cell sustainment via OX40 [58]. This evidence concerns the gene CD4 and systemic lupus erythematosus.